BGM (BGM) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
25.1M
Gross Profit
4.1M
16.39%
Operating Income
-357.4K
-1.42%
Net Income
-1.5M
-6.04%
Balance Sheet Metrics
Total Assets
53.0M
Total Liabilities
8.9M
Shareholders Equity
44.1M
Debt to Equity
0.20
Cash Flow Metrics
Operating Cash Flow
-235.8K
Free Cash Flow
-3.4M
Revenue & Profitability Trend
BGM Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 25.1M | 46.5M | 64.9M | 57.1M | 50.0M |
| Cost of Goods Sold | 21.0M | 44.7M | 58.6M | 51.5M | 42.5M |
| Gross Profit | 4.1M | 1.8M | 6.2M | 5.6M | 7.5M |
| Operating Expenses | 4.5M | 4.2M | 3.7M | 2.7M | 1.6M |
| Operating Income | -357.4K | -2.4M | 2.5M | 3.0M | 5.9M |
| Pre-tax Income | -2.1M | -7.9M | 1.6M | 3.4M | 5.8M |
| Income Tax | -620.0K | 219.2K | 194.3K | 255.1K | 864.9K |
| Net Income | -1.5M | -8.1M | 1.4M | 3.1M | 4.9M |
| EPS (Diluted) | - | -$1.08 | $0.15 | $0.45 | $0.72 |
Income Statement Trend
BGM Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 29.8M | 34.5M | 30.0M | 40.4M | 37.5M |
| Non-Current Assets | 23.2M | 16.7M | 34.5M | 35.0M | 10.6M |
| Total Assets | 53.0M | 51.3M | 64.5M | 75.4M | 48.1M |
| Liabilities | |||||
| Current Liabilities | 8.8M | 6.7M | 9.2M | 18.2M | 18.4M |
| Non-Current Liabilities | 134.4K | 246.5K | 382.5K | 509.9K | 877.9K |
| Total Liabilities | 8.9M | 6.9M | 9.6M | 18.7M | 19.3M |
| Equity | |||||
| Total Shareholders Equity | 44.1M | 44.4M | 55.0M | 56.7M | 28.8M |
Balance Sheet Composition
BGM Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -1.5M | -8.1M | 1.4M | 3.1M | 4.9M |
| Operating Cash Flow | -235.8K | -6.1M | 10.6M | 3.5M | 3.0M |
| Investing Activities | |||||
| Capital Expenditures | -2.9M | -1.8M | -3.2M | -3.5M | -449.8K |
| Investing Cash Flow | 2.0M | -2.9M | -3.2M | -24.2M | -366.8K |
| Financing Activities | |||||
| Dividends Paid | 0 | -1.8M | 0 | - | 0 |
| Financing Cash Flow | -983.5K | -4.6M | -11.9M | 16.3M | -2.9M |
| Free Cash Flow | -3.4M | -3.4M | 9.4M | -3.1M | 4.6M |
Cash Flow Trend
BGM Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
15.00
Price to Book
2.22
Price to Sales
80.80
Profitability Ratios
Profit Margin
-26.32%
Operating Margin
-5.41%
Return on Equity
-16.52%
Return on Assets
-3.84%
Financial Health
Current Ratio
7.05
Debt to Equity
0.22
Beta
1.46
Per Share Data
EPS (TTM)
-$0.20
Book Value per Share
$5.92
Revenue per Share
$4.18
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| bgm | 2.4B | 15.00 | 2.22 | -16.52% | -26.32% | 0.22 |
| Zoetis | 70.3B | 28.34 | 15.12 | 52.09% | 27.12% | 145.63 |
| Haleon Plc - ADR | 47.2B | 25.01 | 5.88 | 8.95% | 12.84% | 63.41 |
| Regencell Bioscience | 18.5B | - | 1,394.12 | -43.18% | 0.00% | 1.04 |
| Elanco Animal Health | 6.6B | 17.80 | 1.04 | 6.01% | 8.43% | 69.18 |
| Lantheus Holdings | 5.6B | 23.07 | 4.81 | 24.11% | 16.55% | 52.78 |
Financial data is updated regularly. All figures are in the company's reporting currency.